Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes
Type 2 diabetes (T2D) is one of the most frequent mortality causes in western countries, with rapidly increasing prevalence. Anti-diabetic drugs are the first therapeutic approach, although many patients develop drug resistance. Most drug responsiveness variability can be explained by genetic causes...
Main Authors: | Valerio Costa, Antonio Federico, Carla Pollastro, Carmela Ziviello, Simona Cataldi, Pietro Formisano, Alfredo Ciccodicola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/7/1008 |
Similar Items
-
Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
by: Carla Pollastro, et al.
Published: (2015-01-01) -
Pharmacogenetics and pharmacogenomics: The impact of the single nucleotide polymorphisms in drug response
by: Jančić Ivan, et al.
Published: (2015-01-01) -
Genetic variation in human drug-related genes
by: Charlotta Pauline Irmgard Schärfe, et al.
Published: (2017-12-01) -
Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients
by: Viktor Hlavac, et al.
Published: (2018-12-01) -
Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
by: Teresa Iannaccone, et al.
Published: (2021-03-01)